| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 436.350 | 7.857 | 0 | 0 | 0 | 0 | 0 | 0 | -13.325 | 0 |
| Total Income - EUR | 506.600 | 7.964 | 0 | 13.968 | 5.673 | 13.893 | 0 | 23.898 | -11.108 | 0 |
| Total Expenses - EUR | 480.187 | 45.995 | 12.870 | 3.326 | 13.315 | 4.035 | 942 | 1.136 | 185.788 | 518 |
| Gross Profit/Loss - EUR | 26.414 | -38.031 | -12.870 | 10.642 | -7.641 | 9.858 | -942 | 22.762 | -196.895 | -518 |
| Net Profit/Loss - EUR | 21.443 | -38.031 | -12.870 | 10.223 | -7.811 | 9.441 | -942 | 22.060 | -197.153 | -518 |
| Employees | 9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vitasig Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 112.548 | 102.200 | 94.455 | 89.063 | 82.102 | 79.936 | 70.129 | 70.281 | 59.214 | 58.883 |
| Current Assets | 363.423 | 298.044 | 293.650 | 287.942 | 210.258 | 204.789 | 200.419 | 200.437 | 1.524 | 998 |
| Inventories | 0 | 4.933 | 4.849 | 4.760 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 342.616 | 293.034 | 288.257 | 281.444 | 209.546 | 204.665 | 200.368 | 200.396 | 447 | 465 |
| Cash | 20.807 | 77 | 544 | 1.737 | 712 | 124 | 51 | 41 | 1.077 | 533 |
| Shareholders Funds | 231.119 | 167.597 | 174.368 | 180.754 | 105.802 | 113.258 | 101.836 | 124.211 | -73.319 | -73.426 |
| Social Capital | 472 | 534 | 525 | 516 | 506 | 517 | 505 | 507 | 505 | 503 |
| Debts | 336.113 | 299.775 | 213.737 | 196.250 | 186.559 | 171.467 | 168.713 | 146.507 | 134.057 | 133.307 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Vitasig Med Srl